Skip to main content
SpringerLink
Log in

BRAF copy number gains in thyroid tumors detected by fluorescence In Situ hybridization

  • Clinical Research
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Point mutation of the BRAF gene is a common genetic event in papillary thyroid carcinomas. More recently, it has been found that BRAF can also participate in chromosomal rearrangement. In this study, we explore yet another possible mechanism of BRAF alteration, which involves copy number gain. Using fluorescence in situ hybridization with BRAF specific and chromosome 7 centromeric probes, we studied 62 follicular thyroid tumors and 32 papillary carcinomas. We found that numerical changes in BRAF copy number were rare in papillary thyroid carcinomas, while they occurred in 16–45% of follicular tumors of conventional and oncocytic (Hürthle cell) types. They were due to amplification of the gene or gain of one or more copies of chromosome 7. Tetrasomy for chromosome 7 was overall the most common finding. The changes in BRAF copy number did not overlap with RAS mutations in follicular tumors. In a group of follicular carcinomas, tumors with BRAF copy number gain were significantly more often widely invasive (67%) compared to tumors with no copy number change (18%). By Western blotting, the tumors carrying four copies of the gene revealed higher expression of BRAF protein, suggesting that copy number gain may represent another mechanism of BRAF activation in thyroid tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9:180–186, 1997.

    Article  PubMed  CAS  Google Scholar 

  2. Tallini G. Molecular pathobiology of thyroid neoplasms. Endocr Pathol 13:271–288, 2002.

    Article  PubMed  CAS  Google Scholar 

  3. Vecchio G, Santoro M. Oncogenes and thyroid cancer. Clin Chem Lab Med 38:113–116, 2000.

    Article  PubMed  CAS  Google Scholar 

  4. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454–1457, 2003.

    PubMed  CAS  Google Scholar 

  5. Cohen Y, Xing M, Mambo E, et al. BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95:625–627, 2003.

    Article  PubMed  CAS  Google Scholar 

  6. Soares P, Trovisco V, Rocha AS, et al. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22:4578–4580, 2003.

    Article  PubMed  CAS  Google Scholar 

  7. Lima J, Trovisco V, Soares P, et al. BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. J Clin Endocrinol Metab 89:4267–4271, 2004.

    Article  PubMed  CAS  Google Scholar 

  8. Ciampi R, Knauf JA, Kerler R, et al. Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 115:94–101, 2005.

    Article  PubMed  CAS  Google Scholar 

  9. DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon: IARC Press, 2004.

    Google Scholar 

  10. Nikiforova MN, Lynch RA, Biddinger PW, et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318–2326, 2003.

    Article  PubMed  CAS  Google Scholar 

  11. Teyssier JR, Liautaud-Roger F, Ferre D, Patey M, Dufer J. Chromosomal changes in thyroid tumors. Relation with DNA content, karyotypic features, and clinical data. Cancer Genet Cytogenet 50:249–263, 1990.

    Article  PubMed  CAS  Google Scholar 

  12. Belge G, Roque L, Soares J, et al. Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology. Cancer Genet Cytogenet 101:42–48, 1998.

    Article  PubMed  CAS  Google Scholar 

  13. Nikiforov YE. Recent Developments in the Molecular Biology of the Thyroid. In: Lloyd R, ed. Endocrine pathology: differential diagnosis and molecular advances. Totowa, NJ: Humana, 2003; pp. 191–209.

    Google Scholar 

  14. Wan PT, Garnett MJ, Roe SM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116:855–867, 2004.

    Article  PubMed  CAS  Google Scholar 

  15. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 417:949–954, 2002.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH

    Raffaele Ciampi PhD, Zhaowen Zhu MD, PhD &  Yuri E. Nikiforov MD, PhD

Authors
  1. Raffaele Ciampi PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhaowen Zhu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuri E. Nikiforov MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuri E. Nikiforov MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ciampi, R., Zhu, Z. & Nikiforov, Y.E. BRAF copy number gains in thyroid tumors detected by fluorescence In Situ hybridization. Endocr Pathol 16, 99–105 (2005). https://doi.org/10.1385/EP:16:2:099

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/EP:16:2:099

Key Words

Search

Navigation